SULFAMYLON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfamylon, and when can generic versions of Sulfamylon launch?
Sulfamylon is a drug marketed by Rising and Mylan Institutional and is included in two NDAs.
The generic ingredient in SULFAMYLON is mafenide acetate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mafenide acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFAMYLON?
- What are the global sales for SULFAMYLON?
- What is Average Wholesale Price for SULFAMYLON?
Summary for SULFAMYLON
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Clinical Trials: | 2 |
Patent Applications: | 4,741 |
Drug Prices: | Drug price information for SULFAMYLON |
What excipients (inactive ingredients) are in SULFAMYLON? | SULFAMYLON excipients list |
DailyMed Link: | SULFAMYLON at DailyMed |
Recent Clinical Trials for SULFAMYLON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mylan Bertek Pharmaceuticals | Phase 4 |
Mylan Pharmaceuticals | Phase 4 |
The University of Texas Medical Branch, Galveston | Phase 2/Phase 3 |
Pharmacology for SULFAMYLON
Drug Class | Methylated Sulfonamide Antibacterial |
US Patents and Regulatory Information for SULFAMYLON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Institutional | SULFAMYLON | mafenide acetate | FOR SOLUTION;TOPICAL | 019832-003 | Jun 5, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SULFAMYLON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SULFAMYLON
See the table below for patents covering SULFAMYLON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Belgium | 695694 | ⤷ Sign Up | |
Israel | 27594 | ANTIBACTERIAL COMPOSITIONS CONTAINING P-AMINOMETHYLBENZENESULFONAMIDE SALTS WITH ORGANIC ACIDS | ⤷ Sign Up |
United Kingdom | 1145193 | ⤷ Sign Up | |
France | 6287 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |